Literature DB >> 9307475

Belsey Mark IV antireflux procedure for complicated gastroesophageal reflux disease.

K N Fenton1, J I Miller, R B Lee, K A Mansour.   

Abstract

BACKGROUND: Over the past 20 years, medical management of gastroesophageal reflux disease has met with increasing success, but a proportion of patients continue to have symptoms or complications requiring surgical treatment. The variety of operations available attests to the general lack of satisfaction with any single procedure.
METHODS: A retrospective study was conducted of 276 patients who underwent the Belsey Mark IV antireflux procedure at our institution between 1979 and 1995. The indication for operation was gastroesophageal reflux disease refractory to medical therapy in 137 patients, gastroesophageal reflux disease with symptomatic stricture or Schatzki's ring in 36, achalasia or epiphrenic diverticulum in 74, paraesophageal hernia in 27, and esophageal mass in 2. Fifteen patients (5.4%) had undergone prior antireflux operations.
RESULTS: There was one perioperative death (0.4%) resulting from an apparent myocardial infarction in an 87-year-old woman who underwent operation for paraesophageal hernia with volvulus. Two patients had contained leaks diagnosed by routine postoperative contrast studies; both were managed successfully without operation. Two patients required early reoperation for recurrent symptoms: 1 underwent a repeated Belsey Mark IV procedure and the other underwent an esophagogastrectomy. An additional 7 patients experienced late recurrence of symptoms requiring surgical management. The overall complication rate was 10.1%, with minor pulmonary complications (2.1%) and atrial arrhythmias (1.8%) occurring most commonly.
CONCLUSIONS: The Belsey Mark IV procedure is a safe and effective operation for the management of gastroesophageal reflux disease with complications, and it compares favorably with other antireflux procedures.

Entities:  

Mesh:

Year:  1997        PMID: 9307475     DOI: 10.1016/s0003-4975(97)00625-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

Review 1.  Thoracoscopic Belsey fundoplication with 5-year outcomes.

Authors:  J K Champion
Journal:  Surg Endosc       Date:  2003-06-13       Impact factor: 4.584

2.  Physiologic basis for the treatment of epiphrenic diverticulum.

Authors:  Dhiren Nehra; Reginald V Lord; Tom R DeMeester; Jörg Theisen; Jeffrey H Peters; Peter F Crookes; Cedric G Bremner
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

3.  Video-assisted thoracoscopic esophagomyotomy for achalasia after pulmonary lobectomy.

Authors:  K Mikami; K Kawahara; R Maruyama; H Ueda; T Shirakusa; A Motohiro
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-11

4.  Primary versus redo paraesophageal hiatal hernia repair: a comparative analysis of operative and quality of life outcomes.

Authors:  H Reza Zahiri; Adam S Weltz; Udai S Sibia; Neethi Paranji; Steven D Leydorf; George T Fantry; Adrian E Park
Journal:  Surg Endosc       Date:  2017-05-10       Impact factor: 4.584

5.  Laparoscopic esophagomyotomy with posterior partial fundoplication for primary esophageal motility disorders.

Authors:  J K Champion; N Delisle; T Hunt
Journal:  Surg Endosc       Date:  2000-08       Impact factor: 4.584

6.  [Laparoscopic esophagotomy without diverticular resection for treating epiphrenic diverticulum in hypertonic lower esophageal sphincter].

Authors:  A Müller; H J Halbfass
Journal:  Chirurg       Date:  2004-03       Impact factor: 0.955

7.  The Belsey Mark IV: an operation with an enduring role in the management of complicated hiatal hernia.

Authors:  Charalampos Markakis; Periklis Tomos; Eleftherios D Spartalis; Pavlos Lampropoulos; Leonidas Grigorakos; Dimitrios Dimitroulis; Elias Lachanas; E Andreas Agathos
Journal:  BMC Surg       Date:  2013-07-05       Impact factor: 2.102

8.  Laparoscopic repair of paraesophageal hernias.

Authors:  Michael Latzko; Frank Borao; Anthony Squillaro; Jonas Mansson; William Barker; Thomas Baker
Journal:  JSLS       Date:  2014 Jul-Sep       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.